III 

118TH CONGRESS 

1ST SESSION S. RES. 180 

Expressing support for the designation of April 30, 2023, as ‘‘National 

Adult Hepatitis B Vaccination Awareness Day’’. 

IN THE SENATE OF THE UNITED STATES 

APRIL 27, 2023 

Ms. HIRONO submitted the following resolution; which was referred to the 

Committee on Health, Education, Labor, and Pensions 

RESOLUTION 

Expressing support for the designation of April 30, 2023, 

as ‘‘National Adult Hepatitis B Vaccination Awareness Day’’. 

Whereas up to 2,400,000 individuals in the United States are 

chronically infected with hepatitis B, and up to 2⁄3 of individuals with chronic hepatitis B are unaware of their 

infection; 

Whereas hepatitis B is a viral infection of the liver transmitted via infected blood and other bodily fluids, including through mother-to-child transmission and injection 

drug use; 

Whereas hepatitis B is associated with significant disparities 

among communities of color (including Asian Americans, 

Pacific Islanders, and African immigrants), sexual and 

gender minority communities, and those affected by the 

opioid crisis; 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•SRES 180 IS 

Whereas individuals with chronic diseases, such as diabetes, 

HIV, hepatitis C, and chronic liver disease, and individuals on hemodialysis are at an increased risk for hepatitis 

B co-infection; 

Whereas there is no cure for hepatitis B, and individuals with 

chronic hepatitis B require lifelong medical care; 

Whereas chronic hepatitis B represents 1 of the most common causes of liver cancer; 

Whereas 1 in every 4 individuals with unmanaged chronic 

hepatitis B will develop liver cancer, cirrhosis, or liver 

failure, with liver cancer having a 5-year survival rate of 

only 18 percent in the United States; 

Whereas safe and highly effective vaccines to protect against 

hepatitis B are available; 

Whereas, in accordance with universal childhood hepatitis B 

vaccination recommendations in the United States, infants and children have been routinely vaccinated against 

hepatitis B since the 1990s; 

Whereas all adults between 19 and 59 years of age, and 

adults 60 and older who have hepatitis B risk factors, are 

recommended to be vaccinated against hepatitis B; 

Whereas the hepatitis B vaccine, which is 95 percent effective 

and was the first anticancer vaccine to be developed, is 

projected to have prevented 310,000,000 cases of hepatitis B worldwide from 1990 to 2020; 

Whereas only 30 percent of adults in the United States are 

vaccinated against hepatitis B; 

Whereas the number of reported acute hepatitis B cases increased by 11 percent nationwide from 2014 to 2018; 


pbinns on DSKJLVW7X2PROD with $$_JOB
3 

•SRES 180 IS 

Whereas, as a result of the drug use epidemic, there have 

been significant regional increases in acute hepatitis B 

cases in the United States, including— 

(1) a reported 489 percent increase from 2015 to 

2016 in Maine; 

(2) a reported 114 percent increase from 2009 to 

2013 in Kentucky, West Virginia, and Tennessee; 

(3) a reported 78 percent increase in 2017 in southeastern Massachusetts; and 

(4) a reported 56 percent increase from 2014 to 

2016 in North Carolina; 

Whereas 36 percent of new hepatitis B cases are among individuals who inject drugs; 

Whereas, according to the Centers for Disease Control and 

Prevention, hepatitis B is 50 to 100 times more infectious than HIV and 5 to 10 times more infectious than 

hepatitis C; and 

Whereas there are significant opportunities, particularly with 

respect to the drug use epidemic, to prevent new hepatitis 

B infections and thereby reduce the incidence of liver 

cancer and cirrhosis through efforts to— 

(1) increase adult hepatitis B vaccination; and 

(2) maintain childhood hepatitis B vaccination: Now, 

therefore, be it 

1 Resolved, That the Senate— 

2 (1) supports the designation of April 30, 2023, 

3 as ‘‘National Adult Hepatitis B Vaccination Aware4 ness Day’’; 

5 (2) recognizes the importance of providing sup6 port and encouragement— 


pbinns on DSKJLVW7X2PROD with $$_JOB
4 

•SRES 180 IS 

1 (A) for all adults to be tested for hepatitis 

2 B at least once in their lifetime in accordance 

3 with recommendations; 

4 (B) for individuals susceptible to infection 

5 to be vaccinated against hepatitis B; and 

6 (C) for individuals diagnosed with hepatitis 

7 B to be linked to appropriate care; and 

8 (3) in order to reduce the number of new hepa9 titis B infections and hepatitis B-related deaths, en10 courages a commitment to— 

11 (A) increasing adult hepatitis B vaccina12 tion rates; 

13 (B) maintaining childhood hepatitis B vac14 cination rates; and 

15 (C) promoting provider and community 

16 awareness of adult hepatitis B vaccination. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB